Cargando…
达雷妥尤单抗治疗晚期轻链型淀粉样变的疗效和安全性
OBJECTIVE: The study investigated the efficacy and safety of daratumumab in the treatment of cardiac light chain（AL）amyloidosis. METHODS: We retrospectively analyzed the clinical characteristics, hematologic response, organ response, long-term survival, and adverse events of 20 patients with newly d...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980654/ https://www.ncbi.nlm.nih.gov/pubmed/35231990 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.01.007 |